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ABSTRACT Free nitric oxide (NO) activates soluble guanylate cyclase (sGC), an enzyme, within both pulmonary and
vascular smooth muscle. sGC catalyzes the cyclization of guanosine 5-triphosphate to guanosine 3,5-cyclic monophos-
phate (cGMP). Binding rates of NO to the ferrous heme(s) of sGC have been measured in vitro. However, a missing link in our
understanding of the control mechanism of sGC by NO is a comprehensive in vivo kinetic analysis. Available literature data
suggests that NO dissociation from the heme center of sGC is accelerated by its interaction with one or more cofactors in
vivo. We present a working model for sGC activation and NO consumption in vivo. Our model predicts that NO influences the
cGMP formation rate over a concentration range of 5–100 nM (apparent Michaelis constant  23 nM), with Hill coefficients
between 1.1 and 1.5. The apparent reaction order for NO consumption by sGC is dependent on NO concentration, and varies
between 0 and 1.5. Finally, the activation of sGC (half-life 1–2 s) is much more rapid than deactivation (50 s). We conclude
that control of sGC in vivo is most likely ultra-sensitive, and that activation in vivo occurs at lower NO concentrations than
previously reported.
INTRODUCTION
Nitric oxide (NO) plays key physiological roles as an inter-
cellular messenger in such processes as modulation of blood
flow, platelet inhibition, neurotransmission, regulation of
smooth muscle tone, and host defense (Beckman and Kop-
penol, 1996; Denninger and Marletta, 1999; Ignarro et al.,
1986, 1987; Malinski et al., 1993; Vaughn et al., 1998a;
Wink and Mitchell, 1998). Because of the broad array of
physiologic functions, NO is important to many organ sys-
tems, and a comprehensive understanding of its in vivo
metabolism is critical.
NO is produced intracellularly in many different cell
types by one of several isoforms of nitric oxide synthase.
Once produced, NO can diffuse passively between cells;
however, due to the presence of eleven valence electrons, it
can also be rapidly consumed by several chemical reactions.
In vivo, NO consumption can be approximated by three
chemical reactions (Beckman and Koppenol, 1996): activa-
tion of soluble guanylate cyclase (sGC), rapid reaction with
hemoglobin in blood, and oxidation by superoxide. The
reaction with sGC is a proven signaling pathway for NO in
which activated sGC catalyzes the conversion of guanosine
5-triphosphate (GTP) to cyclic guanosine 3,5-monophos-
phate (cGMP). This pathway is the mechanism by which
NO regulates smooth muscle tone, and thus local blood
flow.
Although much is known about the reaction of NO with
sGC, critical questions remain regarding the mechanism
(including the in vivo concentration range) by which NO
regulates the activity of sGC and the rate of NO consump-
tion by this pathway. Experiments have been performed
under nonphysiological conditions and in several different
systems. In addition, there are explicit discrepancies in
experimental and theoretical predictions regarding neces-
sary and available free NO in vivo.
It has been reported that sGC is 50% activated at 250
nM NO (Stone and Marletta, 1996), which is much higher
than NO concentrations predicted in arterial smooth muscle
(Vaughn et al., 1998a,b). In vitro studies have reported
half-lives for sGC deactivation that range from 1 to 9 min at
physiological conditions (Brandish et al., 1998; Palmer et
al., 1987). Finally, first- and second-order rate expressions
(Vaughn et al., 1998b) do not correlate well with the ex-
perimental in situ monitoring of NO release and diffusion
through smooth muscle (Malinski et al., 1993).
A missing link in our understanding of the reaction be-
tween NO and sGC has been a complete kinetic analysis
under in vivo conditions. Herein, we convert available in
vitro kinetic data into a comprehensive mathematical frame-
work to provide a mechanism by which NO regulates sGC
in vivo, as well as the consumption rate of NO resulting
from this pathway. Ranges are determined for both the Hill
coefficient, nH, and apparent Michaelis constant, Km. We
conclude the following: 1) NO can control the activation of
sGC in vivo over a concentration range of 5–100 nM; 2)
intracellular thiol proteins, or other cofactors, play a critical
role in the deactivation (and thus control) of sGC; 3) the
activation of sGC is roughly an order of magnitude faster
than deactivation; 4) the consumption of NO by this path-
way is zero order for NO concentrations 200 nM; and 5)
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the Hill coefficient is 1, thus sGC is most likely an
ultra-sensitive enzyme.
METHODS OF ANALYSIS
In mammals, sGC is a 150-kDa heterodimer, consisting of 1 (74–82 kDa)
and 1 (69–74 kDa) subunits (Brandish et al., 1998, Makino et al., 1999;
Tomita et al., 1997). In the absence of NO, the prosthetic heme moiety is
ligated by an axial histidine (His) residue, and exists as a five-coordinate
histidyl complex (Denninger and Marletta, 1999; Stone and Marletta, 1994;
Zhao et al., 1998a,b). This heme ligand has been identified as 1-His-105,
located 105 amino acid residues from the NH2-terminus of the 1 subunit
(Zhao and Marletta, 1997; Zhao et al., 1998b). Free NO binds to the heme
and can increase the activity of sGC up to 400-fold above basal (Stone and
Marletta, 1995).
NO binding mechanism
A previous study (Stone and Marletta, 1996) investigated the activation of
sGC by free NO in vitro under anaerobic conditions at 10°C, and proposed
a complex NO binding mechanism. However, these experiments were
affected by the presence of dithiothreitol, a di-thiol, which reacts with free
NO in a manner similar to glutathione (GSH) and cysteine (Hogg et al.,
1996; Wong et al., 1998).
Based on stopped-flow spectroscopy data obtained at 4°C with initial
NO concentrations, [NO]initial, in the range 570–500,000 nM, a simplified
binding mechanism has been proposed (Zhao et al., 1999). This mechanism
is depicted in Fig. 1 (solid lines) and assumes that sGC consists of a single
fraction. In the first binding phase, the basal form of sGC, E1, binds NO to
form a 6-coordinate nitrosyl complex, E2. In the second phase, E2 is slowly
converted to the 5-coordinate nitrosyl complex, E3, by two parallel path-
ways (one NO-dependent and one NO-independent), as the axial histidine
(His) bond to the heme iron (Fe) is broken. The NO-dependent pathway is
characterized by the irreversible, second-order constant, k3. We assumed
that free NO participating in this reaction is decomposed to another species.
We considered the NO-independent pathway to be reversible, as charac-
terized by first-order constants, k2 and k2. This mechanism provides the
starting point for our model development. The apparent rate constants,
quoted for NO binding at 4°C are: 0.14 nM1s1, 50 s1, 0.0087 s1, and
0.00024 nM1s1, for k1, k1, k2, and k3, respectively (Zhao et al., 1999).
NO dissociation rates and mechanism
NO dissociation from sGC has been studied in vitro at temperatures of 20
and 37°C (Brandish et al., 1998; Kharitonov et al., 1997a,b; Magulis and
Sitaramayya, 2000). Dissociation rate data has been expressed in terms of
an observed pseudo-first-order rate constant, kD,obs.
One laboratory used NO scavengers (i.e., hemoglobin or myoglobin) to
maintain free NO concentrations at very low levels in solution, and
observed that addition of GTP increased kD,obs from 6–8  104 to 3–5 
102 s1 at 20°C (Kharitonov et al., 1997a,b). This apparent GTP effect is
consistent with a previous resonance Raman spectroscopy study (Tomita et
al., 1997), and other recent data (Magulis and Sitaramayya, 2000). How-
ever, another study (Brandish et al., 1998) observed virtually no change in
kD,obs upon addition of GSH and GTP.
We modified the most recent binding mechanism (Zhao et al., 1999) to
include dissociation of NO from the E3 form of sGC (dashed lines in Fig.
1). NO dissociation from sGC is characterized by the first-order rate
constants k2 and kD. Recent data (Eu et. al., 2000) suggest that large
protein thiols are an efficient sink or scavenger of NO to form nitrosothiols.
In vivo, intracellular GSH concentrations can reach 10 nM, and large
protein thiols are present at even higher concentrations. On this basis, we
assumed that intracellular thiols are present in excess. Our modified mech-
anism assumes k2 to account for NO dissociation from sGC in the absence
of in vivo cofactors, and kD for accelerated NO dissociation in vivo (Palmer
et al. 1987). Any NO dissociating from sGC via the kD pathway is assumed
to be rapidly decomposed (Hogg et al. 1996, Wong et al. 1998). Although
current experimental data cannot distinguish between dissociation of NO
from E3 to either E2 or E1, this mechanism is a starting point for simulation
of sGC regulation by NO in vivo.
cGMP production
Different forms of sGC catalyze conversion of GTP to cGMP at different
rates. The rate of cGMP formation, VcGMP, depends upon the concentra-
tions of the different forms of sGC, their respective turnover numbers, and
upon NO concentration. The specific activity of sGC has been correlated in
terms of the maximum reaction rate, Vmax, and apparent Michaelis con-
stant, Km,GTP, with GTP as the substrate. In general, the apparent Km is
defined as the substrate concentration, which produces 50% of full enzyme
activity (Stryer, 1995), but does not necessarily imply Michaelis–Menten
kinetics. Apparent Km,GTP values for the basal and fully activated forms of
sGC have been determined as 85–120 M and 58 M, respectively
(Ignarro et al., 1982). Under in vivo conditions within smooth muscle, GTP
is present in excess ([GTP] 1 mM  1000 M); thus, enzyme activity is
independent of [GTP] (i.e., the dependence of VcGMP on [GTP] can be
ignored). Thus, under these conditions, we can write
dcGMP	
dt  VcGMP kGCBE1 kGC6E2 kGC5E3 , (1)
FIGURE 1 Proposed in vivo mechanism for the bind-
ing of free NO to sGC based on in vitro data (Zhao et al.,
1999). Solid lines, experimentally observed phenomena;
dashed lines, proposed features based on analysis of in
vitro data, as characterized by rate constant, kD.
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where t is time (seconds), and kGCB, kGC6, and kGC5 are the turnover
numbers (s1) for the basal, 6-coordinate nitrosyl and 5-coordinate nitrosyl
forms of sGC, respectively (see Fig. 1). E1, E2, and E3 (represented in
matrix form by vector E, see Eq. 3) are the concentrations of sGC species
(nM), subject to the constraint: E0  E1 
 E2 
 E3, where E0 represents
the total sGC concentration.
Thus, computation of VcGMP requires determination of E1, E2, and E3,
which, in general, are functions of time and space. However, if NO binding
proceeds rapidly compared to cGMP formation, these enzyme concentra-
tions may be expressed in terms of NO concentration, [NO].
NO consumption rates
Within smooth muscle, in vivo consumption of NO via reaction with sGC
is coupled with the reduction of sGC-NO. Adding the decomposition rate




dt  RNO k1NO	E1 k1E2 k3NO	E2 . (2)
The first two terms of Eq. 2 represent the forward and reverse rates of NO
consumption in the first binding phase, and the last term represents NO
consumed by the NO-dependent pathway of the second binding phase (see
Fig. 1).
Numerical methods
Assuming elementary reactions, transient mass balances on the sGC spe-
cies for a well-mixed, constant-volume system, yield the matrix expression,
dE
dt  AEE BEE0 . (3)
The matrix, AE, and vector, BE, are derived from the mechanism depicted
in Fig. 1.
If [NO] is maintained at a constant level within the cell, Eq. 3 can be
integrated analytically to obtain a transient solution. If [NO] is a complex
function of time, or depends strongly upon its consumption and diffusion
rates in vivo, Eq. 3 must be integrated numerically. Under certain physi-
ological conditions, the pseudo-steady-state approximation (PSSA) can be
applied to the enzyme species (Bray and White, 1966). Although sGC is
confined inside the cells, living matter otherwise constitutes an open
system with a continuous supply of free NO and GTP, and continuous
removal of cGMP. Hence, despite transient fluctuations in vivo, pseudo-
steady-state should be attained rapidly under normal physiological condi-
tions. Applying PSSA by setting the time derivatives to zero in Eq. 3, we
obtain
EAE1BEE0 , (4)
where AE1 is the inverse of the matrix AE.
Simultaneous solution of Eq. 4 yields expressions for the individual
enzyme species in terms of [NO] and the rate constants defined by Fig. 1.
Substitution of these expressions into Eq. 2 yields the following expression








where A0  ((k1 
 k2)kD 




k2)k1)/k1k3, and BNO  kDk2/k3(2kD 
 k-2). As [NO] 3 , RNO 3
RNO,max  (2kD 
 k2)E0, the maximum possible NO consumption rate
resulting from the activation of sGC. At [NO]  [NO],50  Km,, the
apparent Michaelis constant for NO consumption with NO as the substrate,
  RNO/RNO,max  0.5. [NO],10 and [NO],90 are defined as the NO
concentrations for which   0.1 and   0.9, respectively. It will be
shown that, at these concentration levels, RNO undergoes its transition to
zeroth order behavior.
Substituting appropriate expressions for the individual enzyme species









where BB  kD/k1, B6  (kD 
 k-2)/k3, B5  k2/k3, 	GCB  kGCB/kGC5 and
	GC6 kGC6/kGC5. For these coefficients, the subscript denotes the form of
the enzyme (basal (B), 6-coordinate nitrosyl (6), and 5-coordinate nitrosyl
(5) complexes). For [NO]  0, the enzyme exists exclusively in its basal
form, and VcGMP,B  kGCBE0. As [NO] 3 , VcGMP 3 VcGMP,max 
kGC5E0, where VcGMP,max is the maximum possible cGMP formation rate.
At [NO]  [NO],50  Km,, the apparent Michaelis constant for cGMP
production with NO as the substrate, VcGMP/VcGMP,max 0.5. We also
define [NO],10 and [NO],90 as the NO concentrations for which VcGMP
 0.1VcGMP,max and VcGMP  0.9VcGMP,max, respectively. The concentra-
tion range between [NO],10 and [NO],90 represents the physiological
range of control for sGC activation.
Statistical analysis and parameter estimation
We focused on the in vivo rate of NO consumption resulting from sGC
activation alone by excluding side reactions of free NO with other species.
From Eq. 5, the fractional (relative) NO consumption rate,   RNO/
RNO,max, is a function of [NO] and the inputs (independent variables, Xj):
k1, k1, k2, k2, k3, and kD. Similarly, from Eq. 6, the fractional (relative)
cGMP formation rate,   VcGMP/VcGMP,max, also depends upon two
additional inputs: 	GCB  kGCB/kGC5 and 	GC6  kGC6/kGC5. On this basis,
outputs (dependent variables, Yi) were selected for statistical analysis, as
defined below. We assessed each output’s sensitivity to the inputs by using





(ln Xj), as an index (Doctor, 1989). Si,jr represents the fractional change of
Yi per fractional change in Xj.
sGC regulation by NO in vivo can be characterized by the rate of
transition from zero to maximal activity and the concentration at which this
transition occurs. Thus, four outputs, each for  and  were evaluated: 1)
the apparent Michaelis constants, Km, and Km,; 2) the [NO] levels at
10% of maximum rate, [NO],10 and [NO],10; 3) the [NO] levels at 90%
of maximum rate, [NO],90 and [NO],90; and 4) the Hill coefficients, nH,
and nH,. nH, and nH,, are defined as the logarithmic slopes of /(1 

























at  0.5. (8)
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Typically, nH  1 for enzymes exhibiting Michaelis–Menten behavior,
nH  1 for sub-sensitive enzymes, and nH  1 for ultra-sensitive enzymes
(Stryer, 1995; Ferrell and Machleder, 1998; Koshland, 1998).
Table 1 summarizes the input parameter values assumed for this anal-
ysis. Each median value and standard deviation (SD), shown in Table 1,
corresponds to the 50-percentile and square root of the variance for each
assumed distribution, respectively. Gaussian distributions were established
for 	GCB kGCB/kGC5 and 	GC6 kGC6/kGC5, from our analysis of specific
activity data (Brandish et al., 1998; Makino et al., 1999; Tomita et al.,
1997; Stone and Marletta, 1995, 1998; Zhao et al., 1999). The activity of
the 6-coordinate complex was assumed to be intermediate between that of
the basal and 5-coordinate nitrosyl forms of sGC, based on our analysis of
in vitro data (Zhao et al., 1999). It is important to note that  and  are
independent of E0, which is not well characterized. However, kGC5 has
been measured in vitro by several investigators at various enzyme concen-
trations (Brandish et al., 1998; Makino et al., 1999; Tomita et al., 1997;
Stone and Marletta, 1995, 1998; Zhao et al., 1999).
The upper limit assumed for kD,obs with dithiothreitol and GTP both
present, was 0.05 s1 at 20°C (Kharitonov et al., 1997a,b), which corre-
sponds to 0.2 s1 at 37°C, based on the rate constant doubling for every
10°C rise in temperature (Bray and White, 1966). Referring to Fig. 1, it can
be verified algebraically that kD,obs  kD 
 k2. Hence, k2 was estimated
as 0.002  0.002 s1 (SD) at 37°C from appropriate dissociation rate data
(Brandish et al., 1998; Kharitonov et al., 1997a,b; Magulis and Sitara-
mayya, 2000). Similar analysis confirms the upper limit: kD kD,obs 0.2
s1 at 37°C. The lower limit for kD was taken as zero, because one study
reported no increase in NO dissociation rates when GSH or GTP were
added (Brandish et al., 1998). The assumed mean, kD  kD,obs  0.01 s1
at 37°C, was based on in vivo experiments (Palmer et al., 1987), which
involved the NO-induced relaxation/contraction of rabbit aorta. The loga-
rithm of kD was assumed to be uniformly distributed between its median
(0.01 s1) and upper limit (0.2 s1), respectively. kD was varied between
its upper and lower limits in assessing the dependence of  and  upon
[NO].
To assess uncertainty, we extrapolated rate constants from 4 to 37°C by
applying the Arrhenius equation (Bray and White, 1966):
ki ki0expEai/R1/T 1/T0	, (9)
where subscript i denotes a step of the binding process (see Fig. 1), Eai is
the activation energy (J/mol) and R is the ideal gas law constant. T and T0
are the absolute temperatures, 277 and 310 K, respectively. Eq. 9 was also
applied to the reverse reactions by replacing i with i. Based on literature
data for similar reactions (Bray and White, 1966), Eai was fitted to a normal
distribution in the range, 13  6 kcal/mol (55  25 kJ/mol) (SD). ki was
then computed from Eai (i  1, 2, 3, 1).
As shown in Table 1, the uncertainties associated with the rate constants
are high due to their exponential dependence upon the activation energies.
Therefore, temperature extrapolation represents a potential source of error.
In addition, the temperature dependence of the equilibrium constant for the
first binding phase, K1  k1/k-1, is not well characterized, because the heat
of reaction is unknown and appropriate data is available only at 4°C (Zhao
et al., 1999). From the literature values quoted (Zhao et al., 1999) and the
input parameter values summarized in Table 1, the corresponding median
value is K1 0.14 nM1s1/50 s1 2 nM1s1/600 s1 0.003 nM1.
Thus, this analysis assumes that K1 is independent of temperature, which is
equivalent to zero heat of reaction. In reality, we would expect K1 to
decrease or increase with temperature for an exothermic or endothermic
reaction, respectively (Bray and White, 1966).
We applied Latin hypercube sampling (LHS) (McKay et al., 1979) to
estimate the probability density functions for each output (D’Agostino and
Stephens, 1986; Greenwood and Nikulin, 1996; Mendenhall and Scheaffer,
1973; Silverman, 1986). LHS was used to select 1000 unique combinations
of the eight inputs listed in Table 1. Each combination was chosen to be of
equal probability based on the assumed input distribution functions (see
Table 1). Probability density functions for the outputs were determined by
making preliminary nonparametric estimates (Mendenhall and Scheaffer,
1973; Silverman, 1986), followed by parametric correlation to standard
probability distribution families (D’Agostino and Stephens, 1986; Green-
wood and Nikulin, 1996; Mendenhall and Scheaffer, 1973).
Transient activation of sGC by NO
An exact simulation of sGC activation in vivo requires numerical integra-
tion of Eq. 3, and a mathematical description of both diffusion rates and
NO consumption resulting from species other than sGC. We considered
two simplified scenarios in which the level of NO was abruptly changed
everywhere within the cell at initial conditions (t  0) from [NO]  0 to
500 nM (sGC activation) and from 500 nM to 0 (sGC deactivation). Initial
conditions for the enzyme species were determined from Eq. 4. Eq. 3 was
integrated to determine E(t), with the resulting expressions substituted into
Eq. 1, to determine VcGMP(t). VcGMP(t) was normalized to the function,
(t)  (VcGMP(t)  VcGMP,B)/(VcGMP,500  VcGMP,B), where VcGMP,500 is
the steady-state rate of cGMP formation at [NO]  500 nM, as determined
from Eq. 6. (t) was plotted as a function of time for both the activation and
deactivation scenarios with kD  0, 0.01, and 0.2 s1.
Dimensionless representation
From Eqs. 6 and 7, the Hill coefficient for cGMP formation, nH,, and
dimensionless Michaelis constant, Ym,  K1Km,, may be expressed in
terms of five dimensionless variables,  k2/(kD
 k2),  k3/[K1(kD

k2)],   kD/k1, 	GCB, and 	GC6, as
nH,
1 2	GCBv x2 






where K1  k1/k1, u  (1  2	GCB) 
 1  2	GC6  , v  4(1 
2	GCB)(1 
 ), and x  u 
 (u2 
 v)1/2.
For the median input parameter values summarized in Table 1   10,
  100,   1.5  105, 	GC6  0.5, and 	GCB  0.004. In general, for
the two-phase binding mechanism proposed, nH, must lie in the range 0
nH,  2. For Michaelis–Menten kinetics, nH,  1. It can be verified that
TABLE 1 Input parameter values assumed for in vivo
sensitivity analysis
Input Units Median SD*
	GCB
# — 0.004 0.002
	GC6
# — 0.5 0.3
kD§ s1 0.01 0.01
k1¶ nM1s1 2.0 2.0
k2¶ s1 0.1 0.1
k3¶ nM1s1 0.003 0.003
k1¶ s1 600.0 600.0
k2¶, s1 0.002 0.002
*SD  standard deviation.
#Gaussian distribution.
§Logarithm of kD uniformly distributed (upper limit  0.2 s1, lower
limit  0).
¶Ea1, Ea2, Ea3, Ea1, and Ea1 normally distributed around 55  25
kJ/mol (Eq. 9).
Based on dissociation rate data at 20–37°C (Brandish et al., 1998; Khari-
tonov et al., 1997a,b; Magulis and Sitaramayya, 2000).
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sGC approaches Michaelis–Menten behavior if   0. Other, nontrivial
values of the dimensionless variables, for which nH, 3 1, also exist.
RESULTS
cGMP formation and NO consumption
Figures. 2 A and 3 A depict  and , respectively, as
functions of [NO] in vivo, for kD  0, 0.01, and 0.2 s1. 
is a monotonically increasing function of NO over a con-
centration range of 0.1–1000 nM depending on the value of
kD. From inspection of Figs. 2 A and 3 A, the values for
[NO],10, Km,, [NO],90, [NO],10, Km,, and [NO],90 at
the median values of the input parameters are roughly 5, 30,
90, 10, 50, and 200 nM, respectively. Figures 2 B and 3 B
depict the logarithmic slopes as a function of [NO] (frac-
tional change of  and  per fractional change in [NO], or
the relative sensitivities S,[NO]r and S,[NO]r , respectively).
S,[NO]r may be interpreted as the apparent reaction order of
NO consumption with respect to [NO]. From inspection of
these figures, the Hill coefficients, nH, and nH,, are both
1.1, 1.3, and 1.5, with kD  0, 0.01, and 0.2 s1,
respectively.
Statistical analysis
We identified the reaction rate constants (kD, k1, k2, k3, and
k1) as important input parameters, with k2 also playing a
minor role, based on sensitivity analysis. The Michaelis
constants are significantly more sensitive to kD than the Hill
coefficients. The sensitivities of both nH,, and Km,, with
respect to 	GCB, were found to be negligible. The relative
sensitivities of all outputs to k1 and k1, were equal in
magnitude but opposite in sign (data not shown), which
suggests that their dependence on these two parameters may
be expressed in terms of the equilibrium constant, K1.
In Table 2, the means (expected values) and percentiles
are summarized for the eight outputs corresponding to
cGMP formation and NO consumption rates, as estimated
from LHS (McKay et al., 1979) using the input parameter
values listed in Table 1. Expected values were computed
from the estimated probability density functions, and per-
centiles were determined directly from LHS results.
In Fig. 4, A—D, is depicted the probability density func-
tions, f(Yi), estimated for the eight outputs. f(nH,) (Fig. 4 A)
was correlated to the Weibull distribution on two intervals
(D’Agostino and Stephens, 1986). f(nH,) (Fig. 4 B) was
correlated as a gamma distribution (D’Agostino and Ste-
phens, 1986; Greenwood and Nikulin, 1996; Mendenhall
and Scheaffer, 1973; Silverman, 1986). Quartile values of
the Hill coefficients are indicated in Fig. 4, A and B. f(nH,)
is characterized by its abrupt peak at nH,  1. Despite the
high likelihood at nH,  1, nearly 90% of the area under
the f(nH,) curve lies in the region where nH,  1, sug-
gesting ultra-sensitive behavior. In contrast, f(nH,) is much
flatter, with only 70% of the curve area in the region where
nH,  1. The median values for both nH, and nH, are
about the same (1.3) with mean (expected) values of 1.36
and 1.27, respectively.
[NO],10, Km,, [NO],90, [NO],10, Km,, and [NO],90
were all correlated to lognormal distributions (Fig. 4, C and
D), with median values indicated as 3.8, 23, 110, 8, 50, and
250 nM, respectively. These values correlate well with the
predicted values when the median values of the input pa-
rameters are used (see above). As a consequence of their
high variances, these probability density functions are max-
FIGURE 2 (A) Relative cGMP formation rate,   VcGMP/VcGMP,max,
and (B) the logarithmic slope, S,[NO]r , as a function of [NO]. The loga-
rithmic slopes correspond to apparent reaction orders with respect to [NO].
FIGURE 3 (A) Relative NO consumption rate,   RNO/RNO,max, and
(B) the logarithmic slope, S,[NO]r , as a function of [NO]. The logarithmic
slopes correspond to apparent reaction orders with respect to [NO].
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imum at Xj values nearly an order of magnitude lower than
the medians (i.e., ln(Xj) is normally distributed, not Xj)
(D’Agostino and Stephens, 1986; Silverman, 1986). Nearly
94% of the area under the f(Km,) curve lies in the region
where Km,  250 nM. Hence, despite its high expected
value (mean value), 76 nM, the probability that Km,  250
nM is estimated at more than 90%.
Transient sGC activation
In Fig. 5 is depicted the transient activation of sGC by free
NO for the hypothetical activation and deactivation scenar-
ios described above. Activation curves can be characterized
by the time is takes to reach 1⁄2 of maximum activity, t1/2.
Note that t1/2 is inversely related to kD and is 1.8, 1.7, and
1.0 s for kD  0, 0.01, and 0.2 s1, respectively. Figure 5
clearly shows that PSSA can be applied for activation after
only 10 s.
For constant kD, deactivation times are longer, and the
difference between activation and deactivation increases
substantially as kD increases. For the deactivation scenarios,
t1/2  170, 50, and 3.2 s for kD  0, 0.01, and 0.2 s1,
respectively. Although deactivation is essentially complete
within 10 s for kD  0.2 s1, roughly 3 and 9 min are
required to achieve 90% deactivation for kD  0.01 and 0
s1, respectively.
Dimensionless representation of the Hill
coefficient and Michaelis constant
We characterized the Hill coefficient, nH,, over the range
of possible input parameter values by using Eq. 10. nH,
was represented in terms of two dimensionless groups,  
k2/(kD 
 k2) and   k3/(K1(kD 
 k2)), as illustrated in
Fig. 6. The activity of the 6-coordinate sGC complex (	GC6
 kGC6/kGC5) was varied at three levels: 50% (Fig. 6 A), 0%
(Fig. 6 B), and 100% (Fig. 6 C) of full activity. For each plot
shown in Fig. 6, diamonds mark the values of  and 
evaluated at the median input parameter values (see Ta-
ble 1).
Because nH, is very insensitive to 	GCB, we kept 	GCB
fixed at its median value in the construction of Fig. 6.
Although kD exerts significant influence on nH, through the
two dimensionless parameters,  and , the relative sensi-
tivity of nH, upon  was found to be less than 0.1%, even
with kD at its upper limit. Hence, the dependence of nH,
upon  kD/k1 is minor compared to its dependence on ,
, and 	GC6. We therefore set  at its most likely value,
based on the probability distributions summarized in Table
1. The low relative sensitivity of nH, with respect to 
results from its small value. This assumption was confirmed
by comparison of the final results (see Fig. 6) with similar
results computed for   0 (data not shown).
Figure 6 shows that nH, decreases with k2 (in most
cases), increases with k3, and decreases K1. Within the
uncertainty range of the dimensionless groups, it is evident
that nH,  1, which demonstrates that sGC activation by
NO most likely exhibits ultra-sensitive behavior. This result
is consistent with results from LHS (Fig. 4 A). Around the
median value, nH,  1.3, the contours are closely spaced.
Thus, in this region, nH, is relatively sensitive to the input
parameters (i.e., small changes in  or  result in large
changes in nH,). In contrast, there is a broad region where
nH,  1, which becomes even more pronounced as 	GC6
increases (compare Fig. 6, A–C). Hence, as nH, 3 1, it
becomes insensitive to the input parameters.
Figure 7 shows a similar characterization for the apparent
Michaelis constant, Km,. In this plot, we kept both K1 and
  kD/k1 fixed at their median values, 0.003 nM1 and
1.5  105, respectively, but varied  and  over a wide
range. Thus, Fig. 7 is a parametric representation of the
dimensionless group, Ym, (see Eq. 11), which is scaled to
the pseudo-Michaelis constant, K[supstas]m,  IYm,/
0.003 nM1. Although the contour lines are linear on an
arithmetic scale, they are displayed on a logarithmic scale to
show detail. As in Fig. 6, the diamond denotes the values of
 and  at the median input parameter values (see Table 1









[NO],10, nM 0.0055 1.0 3.8 19.0 13.0 270.0
Km,, nM 0.05 8.0 23.0 76.0 67.0 1160.0
[NO],90, nM 0.47 44.0 110.0 270.0 280.0 4210.0
nH, 0.61 1.07 1.32 1.36 1.65 1.97
[NO],10, nM 0.015 3.6 8.0 19.0 21.0 370.0
Km,, nM 1.1 25.0 50.0 93.0 110.0 1380.0
[NO],90, nM 11.0 120.0 250.0 470.0 550.0 13,500.0
nH, 0.12 0.92 1.29 1.27 1.65 1.98
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where Km,  23 nM). Figure 7 demonstrates that Km,




sGC activation and inactivation
If free NO regulates sGC activation in vivo, an extrinsic
factor must facilitate dissociation of NO from sGC to allow
efficacious control of sGC activation. Otherwise, sGC
would remain fully activated in vivo, even at low levels of
NO. For example, a recent study demonstrated that increas-
ing intracellular calcium concentrations, [Ca2
], inhibits
sGC activity in vivo via an noncompetitive mechanism
(Parkinson et al., 1999). Increases in [Ca2
] caused both
Km,GTP and Vmax to decrease for both the basal and NO-
stimulated forms of the enzyme. Because this regulation
mechanism is not yet well understood, additional work is
required to assess its impact, but this represents a potential
source for kD,obs along with protein thiols and GTP.
The results presented above indicate that Km, is depen-
dent upon kD and/or k2. This lends support to the hypoth-
esis that extrinsic factors, such as intracellular protein thiols,
are involved in the regulation of sGC activity. However, the
precise mechanism by which these extrinsic factors control
sGC activity remains unclear. The median parameter values
selected for this study (see Table 1) have assumed that kD is
five-fold larger than k2, which resulted in relatively higher
sensitivities of the outputs to kD than for k2. Conversely, if
we instead assume that k2  kD, this sensitivity behavior
is reversed (data not shown).
PSSA assumes that a continuous supply of NO is avail-
able, which maintains [NO] nearly constant within the cell.
Thus, if pseudo-steady-state conditions apply, NO con-
FIGURE 4 Probability density functions, f(Yi), for the (A) output vari-
ables nH,; (B) nH,; (C) [NO],10 (dotted line), Km, (solid line), and
[NO],90 (dash-dot line); and (D) [NO],10 (dotted line), Km, (solid line),
and [NO],90 (dash-dot line). Median and quartile values are indicated with
percentiles in parenthesis, as summarized in Table 2.
FIGURE 5 Transient activation and deactivation of sGC resulting from
an instantaneous change in [NO] (i.e., from [NO]  0 to 500 nM for sGC
activation, and from 500 nM to 0 for sGC deactivation), for kD  0 (dotted
lines), kD 0.01 s1 (solid lines), and kD 0.2 s1 (dash-dot lines). (t)
(VcGMP(t)  VcGMP,B)/(VcGMP,500  VcGMP,B), where VcGMP,500 is the
steady-state rate of cGMP formation at [NO]  500 nM, and VcGMP,B 
kGCBE0 is the basal cGMP formation rate.
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sumption does not impact the activity of sGC. In contrast, if
a transient pulse of NO is delivered to the cell, [NO] is time
dependent, and we observe a much different relationship
between Km, and the kinetic parameters. Therefore, the
apparent Michaelis constants and Hill coefficients presented
herein should be interpreted as characteristics of sGC acti-
vation independent of NO consumption.
Dissociation of NO from sGC reduces the activity of the
enzyme (as kD increases,  decreases at fixed [NO]). Fur-
thermore, Fig. 2 A illustrates that, for fixed kD, VcGMP rises
from low to maximum activity over a relatively narrow
range of [NO], between [NO],10 and [NO],90. For kD 0,
0.01, and 0.2 s1, respectively, these concentration ranges
are2–50 nM, 5–100 nM, and 30–400 nM NO. Figure 2 B
demonstrates that, for very low or very high [NO], S,[NO]r
approaches zero. However, at intermediate [NO], S,[NO]r is
dependent upon kD and reaches a maximum at some critical
value of [NO] (i.e., 2, 10, and 60 nM, for kD  0, 0.01, and
0.2 s1, respectively). In addition, Fig. 2 B demonstrates
that increasing kD reduces the range of [NO] control (nar-
rower peak), but increases S,[NO]r (higher maximum).
As a result of the competing nature of the NO dependent
and independent pathways, the effective [NO] window for
sGC regulation (i.e., the range of [NO] between 10 and 90%
of full sGC activation) can be characterized by the relative
values of k2 and k3, or by the dimensionless groups,  and
 (see Fig. 6). A broader window corresponds to a lower
Hill coefficient, nH,. If k2 dominates over k3, then nH,3
1, corresponding to a broad window. As k3 increases, nH,
increases, narrowing the window. Therefore, the values of
k2 and k3 are critical for characterization of sGC regulation
by NO.
The 70% probability interval for nH, is 1.1  nH, 
1.5. In addition, statistical analysis estimates the probability
that nH,  1.0 at nearly 90% (see Fig. 4 A). The data
depicted in Fig. 6 demonstrate that sGC approaches Michae-
lis–Menten behavior in a broad domain of  and , which
lies outside the most probable range of the kinetic parame-
ters. We therefore conclude that the “switch” for activating
sGC by NO is most likely ultra-sensitive, and sGC is
characterized by a narrow window of activation (i.e., nH,
 1.0). However, because the distribution function of Fig.
4 A shows a high frequency for nH,  1.0, we cannot rule
out Michaelis–Menten behavior.
A 5–100-nM range is determined herein for Km, (see
Fig. 7), with a median value of 23 nM (see Table 2).
Statistical analysis (see Fig. 4 C) estimates more than 90%
probability that Km, is lower than the 250-nM level previ-
ously reported (Vaughn et al., 1998a; Stone and Marletta,
1996). In addition, Fig. 7 demonstrates that Km, exceeds
200 nM only for values of  and , which lie outside the
FIGURE 6 Hill coefficient, nH,, for the sGC–NO system as a function
of the dimensionless groups,   k2/(kD 
 k2) and   k3/(K1(kD 

k2)), with 6-coordinate sGC complex at (A) 50% of kGC5, (B) 0% of kGC5,
(C) 100% of kGC5. ,  and  evaluated at the median values (see
Table 1).
FIGURE 7 Apparent Michaelis constant for cGMP production, Km,, as
a function of the dimensionless groups,   k2/(kD 
 k2) and  
k3/(K1(kD 
 k2)), with 6-coordinate sGC complex at 50% of kGC5., 
and  evaluated at the median values (see Table 1).
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most probable range of the kinetic parameters. Hence, in
vivo, sGC is activated at much lower levels of [NO] then
previously reported and exhibits a Km, value that is com-
parable to NO concentrations predicted in arterial smooth
muscle (Vaughn et al., 1998a,b). Therefore, previous esti-
mates for the effective distance over which NO can influ-
ence the activation of sGC (Vaughn et al., 1998a) need to be
re-evaluated. However, future experimental studies are
needed with [NO] in the 1–100-nM range to substantiate
this hypothesis. In addition, Km, is strongly dependent
upon K1, which is not well characterized at physiological
temperatures.
NO consumption
Experimental data, involving the in situ monitoring of NO
release and diffusion through the muscle cells of rabbit aorta
(Malinski et al., 1993), has been shown to correlate mod-
estly with first- and second-order rate expressions for NO
consumption (Vaughn et al., 1998b). Assuming that NO
consumption rates within muscle cells are dominated by the
binding of NO to sGC, the results presented herein provide
an alternative rate law for NO consumption, which may
explain discrepancies in these data. With kD  0.01 s1,
RNO is approximately first order with respect to NO for
[NO]  1 nM. With [NO] in the range 1–200 nM, the order
of NO consumption is in the range 1.5–0, and is zero order
as [NO] exceeds 200 nM. Thus, for [NO]  200 nM, nearly
all of the binding sites for sGC are bound with NO, and
further consumption of NO is due only to inactivation of
sGC (i.e., Rmax,NO  (2kD 
 k2)E0). This is consistent
with Fig. 3 A, which shows that NO consumption ( 
RNO/RNO,max) monotonically increases with [NO] indepen-
dent of kD, eventually reaching its maximum value, then
becoming independent of [NO] at high concentrations.
Therefore, as  3 1, NO consumption is independent of
[NO] concentration and the apparent reaction order is zero.
Figure 3 B, which plots the logarithmic slope, S,[NO]r ,
also shows that as [NO] becomes large, S,[NO]r 3 0, inde-
pendent of kD. The behavior at lower concentrations is much
different. For kD  0, S,[NO]r 3 1 at low concentrations,
then passes through a maximum at a critical [NO] before
decreasing to zero. The critical [NO] values are 10 and 30
nM, with maximum S,[NO]r values of 1.3 and 1.6, at kD 
0.01 and 0.2 s1, respectively. However, for kD  0,
S,[NO]r 3 2 as [NO] 3 0, then monotonically decreases
over the range 1–1000 nM.
This behavior is the result of the competing nature of the
two parallel pathways that lead to the active 5-coordinate
sGC complex. As [NO]3 0 with kD  0, NO consumption
will be controlled by the slow NO-dependent pathway
(characterized by k3), because both the first binding phase
(characterized by k1 and k1) and the NO independent
pathway (characterized by k2 and k2) will approach equi-
librium at steady state. Thus, as [NO]3 0 with kD  0, we
observe second-order behavior. However, for kD  k2,
dissociation of NO from the E3 form of sGC controls the
NO consumption rate at steady state by displacing the NO-
independent pathway from equilibrium. Hence, as [NO]3 0
with kD  0, the extent of the NO-dependent pathway
becomes negligible, and we observe first-order behavior.
Transient activation and deactivation sGC by NO
Transient simulation of NO binding to sGC (see Fig. 5)
indicates that sGC activation occurs much more rapidly than
deactivation. In addition, comparison of these results with
previously observed in vivo half-lives of 1–2 min (Palmer et
al., 1987), suggests that the median value, kD  0.01 s1, is
appropriate. Although t1/2 was60 s for inactivation, which
is consistent with the 1–2 min reported for the NO-induced
relaxation/contraction of rabbit aorta, additional processes,
which were not considered in our analysis, would tend to
increase the response time. These processes introduce ad-
ditional lag times resulting from diffusion of NO to the cell,
finite cGMP conversion rates, and other downstream ele-
ments of the cGMP signaling cascade.
The proposed mechanism assumes that the observed
pseudo-first-order rate constant for NO dissociation is
kD,obs  kD 
 k2. Because available dissociation rate data
cannot distinguish between the relative contributions of
these two rate constants, we have estimated kD and k2
based on dissociation rate data in the presence and absence
of in vivo cofactors, respectively. The precise sGC deacti-
vation mechanism is not well understood. Hence, an alter-
native approach is to correlate the output parameters in
terms of the observed rate constant, kD,obs  kD 
 k2, by
using a “pseudo-mechanism,” in which the fully-activated,
E3, form of sGC was converted to its basal, E1, form via a
first-order process (in other words, set kD  kD,obs and set
k2  0.). Such a pseudo-mechanism would simplify anal-
ysis and may be useful for the correlation of sGC activity
with [NO] in vivo; however, it may not accurately depict the
precise nature of sGC deactivation and could not be used to
predict NO consumption rates.
CONCLUSION
sGC activation and deactivation by NO is likely regulated
by interaction with intracellular protein thiols or other co-
factors, such as calcium and GTP. Results indicate that the
cGMP formation rate reaches 50% of its maximum value
for [NO]  100 nM, with a Hill coefficient in the range
1.1–1.5. Hence, we conclude that sGC can be partially
activated at [NO] well below the reported 250 nM, and
control of activation is most likely ultra-sensitive. The ap-
parent reaction order for NO consumption via its interaction
with sGC is not constant, but varies with [NO]. Future
experimental studies should focus on monitoring [NO] lev-
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els in vitro, determining chemical equilibrium, using in vivo
(37°C) temperatures when possible, and quantifying sGC
activity with [NO] in the range 1–100 nM.
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